(AFIB)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

AFIB Insider Transactions

Transaction Date
(SEC Report )
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2023-03-01 Sohn Tom officer: SVP, Gen. Counsel & Secretary 42,500 A-Award A 42,500 1.41 59,925.00
2023-03-01 Sohn Tom officer: SVP, Gen. Counsel & Secretary 99,588 A-Award A 42,500 0.00 0.00
2023-03-01 Piscitello Charlie officer: SVP, Chief People Officer 42,500 A-Award A 42,500 1.41 59,925.00
2023-03-01 Piscitello Charlie officer: SVP, Chief People Officer 86,538 A-Award A 42,500 0.00 0.00
2023-03-01 Mukai Takeo officer: CFO 47,500 A-Award A 47,500 1.41 66,975.00
2023-03-01 Mukai Takeo officer: CFO 83,948 A-Award A 47,500 0.00 0.00
2023-03-01 Roman David officer: President & CEO 135,000 A-Award A 135,000 1.41 190,350.00
2023-03-01 Roman David officer: President & CEO 383,159 A-Award A 135,000 0.00 0.00
2023-03-01 Mathews Kevin officer: SVP, Commercial 42,500 A-Award A 42,500 1.41 59,925.00
2023-03-01 Mathews Kevin officer: SVP, Commercial 66,653 A-Award A 42,500 0.00 0.00
2023-02-01 Sohn Tom officer: SVP, Gen. Counsel & Secretary 57,190 F-InKind D 6,525 1.87 12,201.75
2023-02-01 Mathews Kevin officer: SVP, Commercial 24,153 F-InKind D 3,540 1.87 6,619.80
2023-02-01 Piscitello Charlie officer: SVP, Chief People Officer 44,038 F-InKind D 6,627 1.87 12,392.49
2023-02-01 Roman David officer: President & CEO 248,159 F-InKind D 10,196 1.87 19,066.52
2023-02-01 Mukai Takeo officer: CFO 36,448 F-InKind D 2,855 1.87 5,338.85
2022-10-01 Huennekens R Scott director 5,880 A-Award A 5,880 0.88 5,174.40
2022-10-01 Huennekens R Scott director 10,920 A-Award A 2,520 0.00 0.00
2022-09-01 Mukai Takeo officer: Interim CFO 39,303 A-Award A 20,000 0.00 0.00
2022-09-01 Garland Jason K director 32,500 A-Award A 32,500 1.13 36,725.00
2022-09-01 Garland Jason K director 14,000 A-Award A 14,000 0.00 0.00
2022-08-05 Mathews Kevin officer: SVP, Global Sales 27,693 F-InKind D 134 1.56 209.04
2022-08-05 Sohn Tom officer: SVP, Gen. Counsel & Secretary 63,613 F-InKind D 433 1.56 675.48
2022-08-05 Piscitello Charlie officer: Chief People Officer 49,415 F-InKind D 433 1.56 675.48
2022-08-01 Roman David director, officer: President & CEO 127,335 A-Award A 50,000 1.34 67,000.00
2022-08-01 Roman David director, officer: President & CEO 77,335 D-Return A 50,000 2.41 120,500.00
2022-08-01 Roman David director, officer: President & CEO 50,000 D-Return A 77,335 13.66 1,056,396.10
2022-08-01 Roman David director, officer: President & CEO 258,355 A-Award A 75,000 0.00 0.00
2022-07-25 Sohn Tom officer: SVP, Gen. Counsel & Secretary 103,956 D-Return A 32,000 2.41 77,120.00
2022-07-25 Sohn Tom officer: SVP, Gen. Counsel & Secretary 101,156 D-Return A 34,800 13.66 475,368.00
2022-07-25 Sohn Tom officer: SVP, Gen. Counsel & Secretary 107,934 D-Return A 28,022 18.00 504,396.00
2022-07-25 Sohn Tom officer: SVP, Gen. Counsel & Secretary 135,956 A-Award A 32,000 1.34 42,880.00
2022-07-25 Sohn Tom officer: SVP, Gen. Counsel & Secretary 94,822 D-Return A 41,134 14.81 609,194.54
2022-07-25 Mathews Kevin officer: SVP, Global Sales 37,050 D-Return A 20,000 2.41 48,200.00
2022-07-25 Mathews Kevin officer: SVP, Global Sales 57,050 A-Award A 20,000 1.34 26,800.00
2022-07-25 Mathews Kevin officer: SVP, Global Sales 41,583 D-Return A 15,467 13.66 211,279.22
2022-07-25 Mathews Kevin officer: SVP, Global Sales 35,467 D-Return A 21,583 18.00 388,494.00
2022-07-25 Piscitello Charlie officer: Chief People Officer 114,240 D-Return A 32,500 2.41 78,325.00
2022-07-25 Piscitello Charlie officer: Chief People Officer 111,940 D-Return A 34,800 13.66 475,368.00
2022-07-25 Piscitello Charlie officer: Chief People Officer 118,718 D-Return A 28,022 18.00 504,396.00
2022-07-25 Piscitello Charlie officer: Chief People Officer 146,740 A-Award A 32,500 1.34 43,550.00
2022-07-25 Piscitello Charlie officer: Chief People Officer 95,322 D-Return A 51,418 13.38 687,972.84
2022-06-30 Flynn James E other: Director by Deputization 1,889,509 A-Award A 1,889,509 1.11 2,100,000.30
2022-06-16 Hinrichs James F. director 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 Hinrichs James F. director 61,311 A-Award A 8,400 0.00 0.00
2022-06-16 Marzouk Shaden director 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 Marzouk Shaden director 12,422 A-Award A 8,400 0.00 0.00
2022-06-16 Pellegrini Niamh Louise director 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 Pellegrini Niamh Louise director 12,572 A-Award A 8,400 0.00 0.00
2022-06-16 Huennekens R Scott director 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 Huennekens R Scott director 8,400 A-Award A 8,400 0.00 0.00
2022-06-16 Sheridan John F director 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 Sheridan John F director 15,947 A-Award A 8,400 0.00 0.00
2022-06-16 Cramp Daniella director 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 Cramp Daniella director 11,623 A-Award A 8,400 0.00 0.00
2022-06-16 Bonita David P director, 10 percent owner 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 Bonita David P director, 10 percent owner 12,422 A-Award A 8,400 0.00 0.00
2022-06-16 ElBardissi Andrew director 19,600 A-Award A 19,600 0.50 9,870.56
2022-06-16 ElBardissi Andrew director 12,422 A-Award A 8,400 0.00 0.00
2022-06-03 Huennekens R Scott director 507,509 S-Sale D 60,000 0.58 34,800.00
2022-06-01 Roman David officer: Chief Financial Officer 183,355 A-Award A 100,000 0.00 0.00
2022-04-01 Roman David officer: Chief Financial Officer 83,355 F-InKind D 3,248 1.30 4,222.40
2022-04-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 45,844 F-InKind D 733 1.30 952.90
2022-04-01 Burgess Vincent J director, officer: Chief Executive Officer 61,469 F-InKind D 3,896 1.30 5,064.80
2022-02-01 Roman David officer: Chief Financial Officer 50,000 A-Award A 50,000 2.41 120,500.00
2022-02-01 Roman David officer: Chief Financial Officer 86,603 A-Award A 50,000 0.00 0.00
2022-02-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 32,000 A-Award A 32,000 2.41 77,120.00
2022-02-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 46,577 A-Award A 32,000 0.00 0.00
2021-11-15 Hinrichs James F. director 52,911 P-Purchase A 40,000 3.78 151,220.00
2021-08-10 Pellegrini Niamh Louise director 4,172 A-Award A 4,172 0.00 0.00
2021-08-10 Pellegrini Niamh Louise director 15,191 A-Award A 15,191 14.38 218,446.58
2021-08-05 McQuillan Steven officer: SVP, Clinical Affairs & QA 14,577 F-InKind D 305 15.52 4,733.60
2021-08-05 Burgess Vincent J director, officer: Chief Executive Officer 65,365 F-InKind D 1,922 15.52 29,829.44
2021-07-19 ORBIMED ADVISORS LLC director, 10 percent owner 4,872,025 P-Purchase A 714,285 14.00 9,999,990.00
2021-07-19 ORBIMED ADVISORS LLC director, 10 percent owner 1,677,361 P-Purchase A 357,143 14.00 5,000,002.00
2021-07-19 Bonita David P director, 10 percent owner 4,872,025 P-Purchase A 714,285 14.00 9,999,990.00
2021-07-19 Bonita David P director, 10 percent owner 1,677,361 P-Purchase A 357,143 14.00 5,000,002.00
2021-07-19 Flynn James E director, 10 percent owner, other: Director by Deputization 1,974,638 P-Purchase A 390,836 14.00 5,471,704.00
2021-07-19 Flynn James E director, 10 percent owner, other: Director by Deputization 3,438,589 P-Purchase A 680,592 14.00 9,528,288.00
2021-06-17 ElBardissi Andrew director 4,022 A-Award A 1,800 0.00 0.00
2021-06-17 ElBardissi Andrew director 7,022 A-Award A 7,022 16.66 116,986.52
2021-06-17 Bonita David P director, 10 percent owner 7,022 A-Award A 7,022 16.66 116,986.52
2021-06-17 Bonita David P director, 10 percent owner 4,022 A-Award A 1,800 0.00 0.00
2021-06-17 Flynn James E director, 10 percent owner, other: Director by Deputization 4,022 A-Award A 1,800 0.00 0.00
2021-06-17 Flynn James E director, 10 percent owner, other: Director by Deputization 7,022 A-Award A 7,022 16.66 116,986.52
2021-06-17 Hinrichs James F. director 12,911 A-Award A 1,800 0.00 0.00
2021-06-17 Hinrichs James F. director 7,022 A-Award A 7,022 0.00 0.00
2021-06-17 Malik Shahzad director 4,022 A-Award A 1,800 0.00 0.00
2021-06-17 Malik Shahzad director 7,022 A-Award A 7,022 16.66 116,986.52
2021-06-17 Marzouk Shaden director 4,022 A-Award A 1,800 0.00 0.00
2021-06-17 Marzouk Shaden director 7,022 A-Award A 7,022 16.66 116,986.52
2021-04-01 Burgess Vincent J director, officer: Chief Executive Officer 158,691 A-Award A 158,691 13.66 2,167,719.06
2021-04-01 Burgess Vincent J director, officer: Chief Executive Officer 67,287 A-Award A 45,065 0.00 0.00
2021-04-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 14,882 A-Award A 9,882 0.00 0.00
2021-04-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 34,800 A-Award A 34,800 13.66 475,368.00
2021-04-01 Roman David officer: Chief Financial Officer 36,603 A-Award A 36,603 0.00 0.00
2021-04-01 Roman David officer: Chief Financial Officer 77,335 A-Award A 77,335 13.66 1,056,396.10
2021-03-17 Sheridan John F director 7,547 A-Award A 3,147 0.00 0.00
2021-03-17 Sheridan John F director 10,882 A-Award A 10,882 19.06 207,410.92
2021-02-03 Cramp Daniella director 9,972 A-Award A 9,972 24.76 246,906.72
2021-02-03 Cramp Daniella director 3,223 A-Award A 2,423 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.